Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Omission of Ureteral Access Sheath in Retrograde Intrarenal Surgery: Surgical and Safety Outcomes from a Single-Center Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

A close look at the evidence on low-intensity shockwave therapy in erectile dysfunction-a systematic review and meta-analysis of randomized controlled trials.

The journal of sexual medicine·2026
Same author

Pyrroloquinoline Quinone Mitigates Testicular Injury and Reduces Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Rats with Testicular Ischemia-Reperfusion Injury.

Antioxidants (Basel, Switzerland)·2025
Same author

Engineered exosome-mediated delivery of MicroRNA let-7i-5p targets toll-like receptor 4 to modulate inflammation and alleviate acute liver injury in septic mice.

International immunopharmacology·2025
Same author

Crebanine Induces Cell Death and Alters the Mitotic Process in Renal Cell Carcinoma In Vitro.

International journal of molecular sciences·2025
Same author

Incidental Detection of Poorly Differentiated Neuroendocrine Carcinoma in Penile Urethra on 18 F-Fluciclovine PET/CT.

Clinical nuclear medicine·2025

Related Experiment Video

Updated: Oct 8, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

439

Prostatic Schwannoma Presenting with Prostate-specific Antigen Elevation: A Case Report.

Benjamin Chung Howe Lai1,2, Hung-Jen Shih3,4,5, Syuan-Hao Syu1,2

  • 1Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

The Yale Journal of Biology and Medicine
|December 31, 2021
PubMed
Summary
This summary is machine-generated.

Prostatic schwannoma is a rare tumor that can present with elevated prostate-specific antigen (PSA). Conservative management with close observation may be a viable long-term treatment option for this uncommon condition.

Keywords:
ProstateProstate-specific antigenSchwannoma

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.4K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K

Related Experiment Videos

Last Updated: Oct 8, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

439
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.4K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K

Area of Science:

  • Urology
  • Oncology
  • Pathology

Background:

  • Schwannomas are rare tumors of the male genital system, typically treated surgically.
  • Prostatic schwannoma is exceptionally uncommon, with few cases reported in medical literature.

Observation:

  • A 65-year-old male presented with an elevated prostate-specific antigen (PSA) level.
  • Digital rectal examination and transrectal ultrasonography revealed a nodule in the left peripheral lobe of the prostate.
  • Histopathological analysis of the biopsy confirmed prostatic schwannoma.

Findings:

  • The patient opted for conservative treatment with regular image follow-up over surgery.
  • Over a 6-year follow-up, mild PSA progression was noted, but symptoms did not worsen.
  • This case highlights PSA elevation as a potential, albeit rare, presenting sign of prostatic schwannoma.

Implications:

  • Conservative management with vigilant monitoring may be a feasible alternative to surgery for select cases of prostatic schwannoma.
  • Long-term survivorship can be achieved with non-surgical approaches for rare prostatic tumors.
  • Elevated PSA should prompt consideration of rare diagnoses like schwannoma in the differential diagnosis.